Brent T Hagen

Title: Brent T. Hagen: Innovator in Oligosialic Acid Derivatives

Introduction

Brent T. Hagen is a notable inventor based in Oakland, California. He has made significant contributions to the field of biochemistry, particularly in the development of oligosialic acid derivatives. With a total of five patents to his name, his work has implications in immunology and cancer treatment.

Latest Patents

Hagen's latest patents focus on the production and application of isolated alpha (2→8) or (2→9) oligosialic acid derivatives. These derivatives are characterized by a non-reducing end enriched with de-N-acetyl residues, which are resistant to degradation by exoneuraminidase. The production method involves treating an oligosialic acid precursor with sodium borohydride to achieve de-N-acetylation. The resulting derivatives have potential uses in protecting against bacterial infections and in diagnosing and treating cancer.

Career Highlights

Throughout his career, Brent T. Hagen has worked with esteemed institutions such as Children's Hospital & Research Center Oakland. His research has contributed to advancements in immunological applications and therapeutic methods.

Collaborations

Hagen has collaborated with Gregory R. Moe, enhancing the scope and impact of his research endeavors.

Conclusion

Brent T. Hagen's innovative work in oligosialic acid derivatives showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the fields of immunology and oncology.